RETRACTED ARTICLE: Type 1 diabetes and the challenges of emotional support in crisis situations: results from a randomized clinical trial of a multidisciplinary teleintervention

Alessi, Janine; Becker, Alice Scalzilli; Amaral, Bibiana; Oliveira, Giovana Berger de; Franco, Débora Wilke; Knijnik, Carolina Padilla; Kobe, Gabriel Luiz; Brito, Ariane de; Carvalho, Taíse Rosa de; Schaan, Beatriz D’Agord; Teló, Gabriela Heiden

doi:10.1038/s41598-022-07005-w

Cited by 3 publications

(4 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, 2086 studies were indexed as randomized controlled trials and 549 as clinical trial protocols (Table 1). Also, using the descriptors, nine studies were retracted [9][10][11][12][13][14][15][16]20]; however, one study was not associated with a COVID-19 intervention, and it was excluded, as well as its retraction note [20] (Tables 1 and 2). During the same period, from January 2019 to December 12, 2022, we observed a total of 202,398 studies published in PubMed using the descriptors ((Clinical Trial) NOT (COVID-19 OR SARS-CoV-2)).…”

Section: Resultsmentioning

confidence: 99%

Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment

Valencise

Palamim

Marson

2023

IJERPH

View full text Add to dashboard Cite

We are presenting an overview of the retracted clinical trials about the Coronavirus Disease (COVID)-19 published in PubMed using the descriptors ((COVID-19 OR SARS-CoV-2) AND (Clinical Trial)). We collected the information for i) the first author’s country; ii) the journal name where the study was published; iii) the impact factor of the journal; iv) the main objective of the study; v) methods including population, intervention, study design, and outcomes; and vi) results and conclusions. We collected complete information from the retraction notes published by the journals and the number of publications/retractions related to non-COVID-19 clinical trials published simultaneously. We also included the Altmetric index for the clinical trials and the retraction notes about COVID-19 to compare the accessibility to both studies’ indexes. The retraction of clinical trials occurred in four countries (one in Lebanon, one in India, one in Brazil, and five in Egypt) and six journals (one in Viruses, one in Archives of Virology, one in Expert Review of Anti-infective Therapy, one in Frontiers in Medicine, two in Scientific Reports, and two in The American Journal of Tropical Medicine and Hygiene). Eight drugs were tested (Ivermectin, Vitamin D, Proxalutamide, Hydroxychloroquine, Remdesevir, Favipiravir, and Sofosbuvir + Daclatasvir) in the studies. One of the retractions was suggested by the authors due to an error in the statistical analysis, which compromised their results and conclusions. Also, the methods, mainly the allocation, were not well conducted in the two studies, and the studies were retracted. In addition, the studies performed by Dabbous et al. presented several issues, mainly including several raw datasets that did not prove their findings. Moreover, two studies were retracted due to data overlap and copying. Significant concerns were raised about the integrity of the data and reported results in another article. We identified a higher Altmetric index for the original studies, proving that the retracted studies were accessed more than the retraction notes. Interestingly, the impact of the original articles is much higher than their retraction notes. The different Altmetric indexes show that possibly people who read those retracted articles are not reading their retraction notes and are unaware of the erroneous information they share. COVID-19- related clinical trials were ~two-time times more retracted than the other clinical trials performed during the same time.

show abstract

Section: Resultsmentioning

confidence: 99%

Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment

Valencise

Palamim

Marson

2023

IJERPH

View full text Add to dashboard Cite

show abstract

“…Twenty‐nine participants were in the intervention group that received weekly telephone contacts with the appointment protocol prepared by a multidisciplinary team that lasted 16 weeks. The results showed a significant decline in emotional distress ( p = 0.43) (Alessi et al., 2022 ).…”

Section: Resultsmentioning

confidence: 97%

“…Participants were individuals prone to mental illnesses like depression and GAD due to the COVID‐19 pandemic and its consequences on lifestyle. Interventions in these studies consisted of a wide range of telecommunication methods, including telephone contacts (Alessi et al., 2021 , 2022 ; Kahlon et al., 2021 ; Lai, Yan, et al., 2020 ), messaging platforms (Aguilera et al., 2021 ), online methods, for example, videoconference, and online apps (Al‐Alawi et al., 2021 ; Fiol‐DeRoque et al., 2021 ; Lai, Yan, et al., 2020 ; Sanchez‐Guarnido et al., 2021 ; Shapira et al., 2021 ; Summers et al., 2021 ; Watts et al., 2020 ; Weerkamp‐Bartholomeus et al., 2020 ). The outcome assessment was different between the articles.…”

Section: Resultsmentioning

confidence: 99%

“…Twenty-nine participants were in the intervention group that received weekly telephone contacts with the appointment protocol prepared by a multidisciplinary team that lasted 16 weeks. The results showed a significant decline in emotional distress (p = 0.43)(Alessi et al, 2022).In the quasi-experimental study conducted bySummers et al, 273 adults who had joined the Gro health app participated. Gro Health is a digital health intervention that provides behavioral change support through structured education and guided activities in mental wellbeing, nutrition, sleep, and exercise.…”

mentioning

confidence: 93%

See 1 more Smart Citation

Tele‐medicine and improvement of mental health problems in COVID‐19 pandemic: A systematic review

Hatami

Deravi

Danaei

et al. 2022

Int J Methods Psych Res

View full text Add to dashboard Cite

Introduction Tele‐medicine services have been developed in response to the COVID‐19 pandemic, which disrupts mental health services. The present study investigates the effectiveness of telephone‐delivered services for psychological disorders in the COVID‐19 pandemic. Methods We searched PubMed/Medline, Embase and Cochrane Controlled Register of Trials for relevant clinical studies up to February 1, 2022. Following terms were used: “severe acute respiratory syndrome”, “Coronavirus”, “Coronavirus infection”, “SARS‐CoV‐2”, “COVID‐19”, “mental disorder”, “mental health”, “mental health program”, “mental health service”, “psychiatric service”, “telemedicine”, “Telehealth”, “Tele‐health”, “Telecare”, “Mobile health”. Results Twelve relevant clinical articles were included in our study. Eight articles were parallel randomized controlled trials (RCTs), two were Quasi‐experimental, and one was a multicenter retrospective cohort study. A total of 1900 adults (18 years old or above that) were included. Online telecommunication methods like online apps and videoconference were the most common interventions. The most prevalent measured outcome was levels of anxiety and depression among participants. Eleven out of 12 articles showed a significant association between telemedicine and mental health improvement. Conclusions The included studies in the current systematic review reported the probable efficacy of telemedicine in improving mental health disorders during the COVID‐19 pandemic. But it is not possible to determine the best telecommunication method for each mental disorder in different populations and the preference of patients is still face to face therapy. So RCTs in different populations with previous mental disorders or chronic diseases are required to investigate the further telemedicine's efficacy on managing mental problems.

show abstract

Lifestyle pattern changes, eating disorders, and sleep quality in diabetes: how are the effects of 18 months of COVID-19 pandemic being felt?

et al. 2022

Self Cite

View full text Add to dashboard Cite

AimsThe pandemic resulted in a lifestyle crisis which may negatively affect patients with diabetes. Despite current knowledge, there is a lack of longitudinal studies evaluating this effect. To assess patients' perceptions about changes in lifestyle, and eating and sleeping patterns after 18 months of the COVID-19 pandemic, and to identify if aspects related to the pandemic (social distancing, COVID-19 infection, behavioral changes, and financial difficulties) are predictors of worsening in eating and sleeping parameters. Methods This was a longitudinal study that followed patients with diabetes from April 2020 to July 2021 in Southern Brazil. Individuals with type 1 or type 2 diabetes, aged ≥ 18 years, were included. The outcome of this study was the assessment of daily habits during a 18-month period of the COVID-19 pandemic. Specific questionnaires were applied once participants were included in this study (3 months after the onset of the pandemic) and at the 18-month follow-up, which included the Eating Attitudes Test-26 (EAT-26), the Mini-Sleep Questionnaire (MSQ), and a specific questionnaire on diet, physical activity, and sleep pattern. Data were compared within and between groups (type 1 and type 2 diabetes), and multivariable models were used to identify subgroups of worse outcomes. Results A total of 118 (78.6%) participants remained in the study at follow-up (mean age 54.6 ± 13.9 years, 41.3% male). In total, 33.9% of participants perceived weight gain during the pandemic, especially those with type 1 diabetes (43.1% vs 25.0% in type 2 diabetes, P = 0.04). About one in four participants reported emotional eating and changes in their eating habits for financial reasons. Regarding sleep patterns, more than half the participants reported taking naps during the day, out of which 30.5% of them perceived worse sleep quality, with no difference between type 1 and type 2 diabetes groups. There were no within-group differences in MSQ and EAT-26 scores. Among participants with type 2 diabetes, age ≥ 60 years (OR 27.6, 95%CI 2.2-345.7), diabetes duration ≥ 15 years (OR 28.9, 95%CI 1.4-597.9), and perceived emotional eating (OR 10.9, 95%CI 1.1-107.5) were associated with worsened food quality. Worse sleep quality during the pandemic was associated with age ≥ 60 years for both type 2 diabetes (OR 5.6, 95%CI 1.1-31.5) and type 1 diabetes (OR 5.5, 95%CI 1.0-29.9). Conclusions Follow-up data from a cohort of patients with diabetes indicate that at the end of 18 months of social distancing, some lifestyle aspects worsened and some improved, showing that these patients responded differently to the adversities of this period. The evidence of clinical features associated with worsening in food and sleep quality provides new insights to prioritizing actions in crisis situations.

show abstract

RETRACTED ARTICLE: Type 1 diabetes and the challenges of emotional support in crisis situations: results from a randomized clinical trial of a multidisciplinary teleintervention

Cited by 3 publications

References 30 publications

Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment

Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment

Tele‐medicine and improvement of mental health problems in COVID‐19 pandemic: A systematic review

Lifestyle pattern changes, eating disorders, and sleep quality in diabetes: how are the effects of 18 months of COVID-19 pandemic being felt?

Contact Info

Product

Resources

About